Clinical trials: chasing recruits

February 2009
CMAJ: Canadian Medical Association Journal;2/17/2009, Vol. 180 Issue 4, p375
Academic Journal
The article focuses on the recruitment of research participants for the clinical studies in Canada. The U.S. Officer of the Inspector General states that the disturbing recruitment practices for clinical participants have been developed because of the increasingly commercial clinical trial business. Regulatory reporting obligations concerning the adverse events related to clinical trials are also noted. With the problems involved to people's participation in clinical trials, it notes the policies on safety and protection of research participants are the prior concerns of ethicists, policymakers, and legislators.


Related Articles

  • Clinical trial participation poses ethical, practical issues. Silversides, Ann // CMAJ: Canadian Medical Association Journal;3/4/2009 Doctor's Health Matters, Vol. 180, p500 

    The article focuses on the ethical and practical concerns related to physician's participation in clinical trials. To address the issues, it mentions that College of Physicians and Surgeons in Ontario has developed a policy on patient recruitment for clinical trials. It notes that the policy...

  • The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials. Weijer, Charles; Grimshaw, Jeremy M.; Eccles, Martin P.; McRae, Andrew D.; White, Angela; Brehaut, Jamie C.; Taljaard, Monica // PLoS Clinical Trials;Nov2012, Vol. 7 Issue 11, p1 

    The Ottawa Ethics of Cluster Trials Consensus Group sets out 15 recommendations for the ethical design and conduct of cluster randomized trials.

  • Taking the plunge. Savulescu, Julian // New Scientist;03/03/2001, Vol. 169 Issue 2280, p50 

    Comments on the risks and rewards of participating in clinical trials and high-risk medical research. Issues of the ethics in paying volunteers and the exploitation of participants in the interest of industry and biomedicine; Assertion that people can make decisions weighing benefit and risk,...

  • A taxonomy of multinational ethical and methodological standards for clinical trials of therapeutic interventions. Ashton, Carol M.; Wray, Nelda P.; Jarman, Anna F.; Kolman, Jacob M.; Wenner, Danielle M.; Brody, Baruch A. // Journal of Medical Ethics;Aug2011, Vol. 37 Issue 8, p368 

    Background If trials of therapeutic interventions are to serve society's interests, they must be of high methodological quality and must satisfy moral commitments to human subjects. The authors set out to develop a clinical-trials compendium in which standards for the ethical treatment of human...

  • Implications of the EU directive on clinical trials for emergency medicine. Singer, Ernst A; Müllner, Marcus // BMJ: British Medical Journal (International Edition);5/18/2002, Vol. 324 Issue 7347, p1169 

    Editorial. Comments on a directive from the European Union meant to implement good clinical practice in the conduct of clinical trials on drugs for human use. Concern about rules for treating incapacitated patients which require a legal representative; How the rule could limit studies in...

  • Post-trial access. Usharani, Pingali; Naqvi, Syed Mujtaba Hussain // Perspectives in Clinical Research;Jan-Mar2013, Vol. 4 Issue 1, p58 

    The article discusses the ethical issues, regulatory guidelines, and major stakeholders' perspective on providing post-trial access (PTA) to participants of a clinical trial. The Declaration of Helsinki provides for PTA and India's revised Ethical Guidelines for Biomedical Research on Human...

  • SPIRIT 2013.  // Evidence-Based Dentistry;Dec2013, Vol. 14 Issue 4, p120 

    The article focuses on the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 statement, which provides a checklist of the recommended items for inclusion in a full clinical trial protocol. The 33-item checklist is split into a number of sections, including...

  • What Physician-Investigators Owe Patients Who Participate in Research. Litton, Paul; Miller, Franklin G. // JAMA: Journal of the American Medical Association;10/6/2010, Vol. 304 Issue 13, p1491 

    The authors reflect on the need to have a clear understanding of the duties of physician-investigators and physicians in clinical practice. They examine the ethical tensions created by clinical research due to the exposure of patient-participants to risks of harm for the sake of generating...

  • GUINEA-PIGGING. Elliot, Carl // New Yorker;1/7/2008, Vol. 83 Issue 42, p36 

    The article discusses volunteers for medical research studies. Pharmaceutical companies have turned to the private sector to conduct research and recruit research subjects by offering high fees. The pharmaceutical company SFBC International allegedly paid immigrants to serve in unlicensed drug...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics